Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-01-06
1986-10-07
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
544120, 544121, 514 19, 544122, 544128, 514222, 544129, 544131, 514230, 544182, 544216, 514231, 544238, 544295, 514232, 544333, 544357, 514234, 544358, 544363, 514241, 544365, 544405, 514242, 546144, 546167, 514252, 546187, 546193, 514269, 546194, 546256, 514307, 546257, 546262, 514314, 546263, 546270, 514316, 546271, 546273, 514318, 546269, 546274, 514332, 546275, 546276, 514333, 546277, 546278, 514337, 546279, 546280, 514338, 546281, 546283, 514339, 546284, 546286, 514340, 546308, 546309, 514341, 546316,
Patent
active
046160027
ABSTRACT:
Compounds of the formula I ##STR1## in which n represents 1, 2 or 3, Ar represents a carbocyclic or heterocyclic aryl radical, Ac represents the acyl radical of an acid, Z represents a radical --OR.sub.7 or --NR.sub.8 R.sub.9, R.sub.1 represents hydrogen, unsubstituted or substituted lower alkyl, a carbocyclic or heterocyclic aryl radical or free, etherified or esterified hydroxy, R.sub.2 and R.sub.3, independently of one another, each represents hydrogen, unsubstituted or substituted lower alkyl, formyl or functionally modified formyl, carboxy or functionally modified carboxy, a carbocyclic or heterocyclic aryl radical or unsubstituted or mono- or di-substituted amino, R.sub.4 represents hydrogen or lower alkyl, R.sub.5 and R.sub.6, independently of one another, each represents hydrogen, unsubstituted or substituted lower alkyl or a carbocyclic or heterocyclic aryl radical, R.sub.7, R.sub.8 and R.sub.9, independently of one another, each represents hydrogen, unsubstituted or substituted alkyl or a carbocyclic or heterocyclic aryl radical; in which R.sub.1 and R.sub.2 together or R.sub.1 and R.sub.3 together may represent unsubstituted or substituted lower alkylene in which a carbon atom is optionally replaced by a hetero atom, in which R.sub.4 and R.sub.5 together, and likewise R.sub.5 and R.sub.6 together and/or R.sub.8 and R.sub.9 together, independently of one another, may represent unsubstituted or substituted lower alkylene in which a carbon atom may have been replaced by a hetero atom, optical isomers of compounds of the formula I, mixtures of these optical isomers and salts of such compounds that have a salt-forming grouping, are distinguished by cardiovascular, especially blood pressure-reducing, properties. They are manufactured in a manner known per se.
REFERENCES:
Jouin et al, J. American Chem. Soc., vol. 103, pp. 2091-2093 (1981).
Eichenberger Kurt
Kamber Bruno
Kuhnis Hans
Leutert Thomas
Ciba-Geigy Corporation
Collins Bruce M.
Glynn Michael W.
Jorda Karl F.
Ramsuer Robert W.
LandOfFree
Dihydro pyridine compounds, compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydro pyridine compounds, compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydro pyridine compounds, compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-643316